MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ

Exclusion Criteria

• •Distance from the balloon surface to the surface of the skin \< 5mm as determined by CT imaging.
• •Distant metastases.
• •Invasive or in-situ lobular carcinoma (post-surgery assessment).
• •Nonepithelial breast malignancies such as sarcoma or lymphoma.
• •DCIS that is multicentric in the ipsilateral breast.
• •Pregnant or lactating.
• •Prior non-hormonal therapy for the present breast cancer, including radiation therapy and/or chemotherapy.
• •Collagen vascular diseases
• •Coexisting medical conditions with life expectancy \< 2 years.
• •Serious psychiatric or addictive disorder
• •Previously treated contralateral breast carcinoma
• •Synchronous bilateral breast carcinoma.
• •Other malignancy, except non-melanoma skin cancer, \< 5 years prior to participation in the study; the disease free interval from any prior carcinoma must be continuous.
• •Patients with diffuse disease